New analysis boosts drug's prostate cancer value

thestar.com.my     May 20, 2008            

WASHINGTON (Reuters) - The drug is finasteride, formerly sold by Merck and Co as Proscar to treat enlargement of the prostate and now available generically. When the initial results of the study were announced, the researchers cautioned that men in the study who developed prostate cancer while... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies